Results 191 to 200 of about 95,645 (304)

INFLUENCE OF GROWTH-HORMONE-RELEASING FACTOR AND (OR) THYROTROPIN-RELEASING FACTOR ON SOMATOTROPIN, PROLACTIN, TRIIODOTHYRONINE AND THYROXINE RELEASE IN GROWING PIGS [PDF]

open access: bronze, 1988
Patrice Dubreuil   +7 more
openalex   +1 more source

Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2011
E. Tatar   +10 more
semanticscholar   +1 more source

Comparative Efficacy of Two‐Session Radiofrequency Ablation Versus Transarterial Embolization Followed by Radiofrequency Ablation for the Treatment of Large Benign Thyroid Nodules

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Purposes To treat large benign thyroid nodules (BTNs), radiofrequency ablation (RFA) and transarterial embolization (TAE) combined with RFA are both used. This study aimed to compare the effectiveness of both treatments. Methods Nineteen subjects with 20 BTNs received two sessions of RFA, while eight patients with 10 BTNs underwent TAE followed by RFA ...
Cheng-Kang Wang   +9 more
wiley   +1 more source

Medium‐Term Study Results of Ultrasound‐Guided Radiofrequency Ablation for Thyroid Follicular Neoplasm With Low SUV in PET/CT

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background This study aimed to evaluate the medium‐term outcomes of radiofrequency ablation (RFA) for thyroid nodules with cytology of follicular neoplasm and low standard uptake value (SUV) in a positron emission tomography (PET/CT) study. Methods Between January 2018 and January 2021, 40 patients diagnosed with follicular neoplasm underwent ...
An-Ni Lin   +8 more
wiley   +1 more source

Evaluation of the Effect of IL‐1 Antagonists on Pituitary Function

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease frequently observed in populations along the Eastern Mediterranean coast, characterized by recurrent fever, abdominal pain, and joint inflammation. The disease results from mutations in the MEFV gene, which plays a critical role in regulating IL‐1β secretion ...
Fadime Aktas Koc   +3 more
wiley   +1 more source

Remission of Persistent Hypothyroidism Following Subacute Thyroiditis After Discontinuation of Thyroxine: A 9‐Year Retrospective Study

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Objective The long‐term outcomes of discontinuing thyroxine replacement therapy in patients with persistent hypothyroidism following subacute thyroiditis are unknown. This study involved an extended follow‐up of a cohort of patients who participated in a clinical trial of prednisone for the treatment of subacute thyroiditis.
Lei Yang   +3 more
wiley   +1 more source

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu   +3 more
wiley   +1 more source

Study of Iodine Content in Commercial Salt of Nepal: Examining Compliance With Regulation, Associated Hazards, and Health Effects

open access: yesInternational Journal of Food Science, Volume 2026, Issue 1, 2026.
Iodine is a vital micronutrient necessary for thyroid hormone synthesis, growth, and neurodevelopment. Universal salt iodization was implemented globally, including in Nepal, to address the burden of iodine deficiency diseases. Despite the success, iodine loss from iodized salt due to temperature and storage practices remains an issue.
Yugesh Paudel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy